Average Co-Inventor Count = 9.26
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoffmann-la Roche Inc. (12 from 4,942 patents)
2. F. Hoffmann-la Roche Ag (168 patents)
12 patents:
1. 12351575 - 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
2. 10683299 - Pyrazolopyrazine and triazolopyrazine compounds for the treatment of infectious diseases
3. 10662203 - Pyrido[2,3-b]indole compounds for the treatment and prophylaxis of bacterial infection
4. 10597380 - Pyridazinone-based broad spectrum anti-influenza inhibitors
5. 10428069 - 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
6. 10081627 - 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
7. 9856247 - 4-methyl-dihydropyrimidines for the treatment and prophylaxis of Hepatitis B virus infection
8. 9758530 - 6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
9. 9447086 - 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
10. 9266904 - 6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
11. 9233978 - 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
12. 8404738 - 4-amino-N-hydroxy-benzamides for the treatment of cancer